We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Evolutec Grp | LSE:EVC | London | Ordinary Share | GB00B01JLR99 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 41.00 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Dec 2019 to Dec 2024
17 November 2015
NANOCO GROUP PLC
("Nanoco" or the "Company")
Director/PDMR Shareholding
Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, is issuing the following notification in accordance with DTR 3.1.2.R.
The Company has been notified that on 17 November 2015, Dr Michael Edelman, Chief Executive Officer of Nanoco, sold 1,357,025 ordinary shares of £0.10 each in the Company ("Ordinary Shares") at an average price of 44.2 pence per share. The reason for the share sale is to satisfy tax and other financial commitments associated with Dr Edelman's relocation to the USA.
In addition to the share sale, the Company has been notified that on 17 November 2015, Dr Edelman also transferred 200,000 Ordinary Shares (for nil consideration) as a charitable donation.
Following the transaction, Dr Edelman is interested in 5,431,615 Ordinary Shares, representing 2.29% per cent of the Company's issued share capital.
For further information, please contact:
|
Nanoco |
Tel: +44 (0) 161 603 7900 |
|
Michael Edelman, Chief Executive Officer |
|
|
David Blain, Chief Financial Officer Caroline Watson, Investor Relations Manager cwatson@nanocotechnologies.com |
Tel: + 44 (0) 7799 897357 |
|
|
|
|
Canaccord Genuity - Joint Broker |
Tel: +44 (0) 20 7523 8000 |
|
Simon Bridges Cameron Duncan |
|
|
Mark Whitmore |
|
|
|
|
|
Liberum - Joint Broker |
Tel: +44 (0) 20 3100 2000 |
|
Neil Patel |
|
|
Richard Bootle Steven Tredget |
|
|
|
|
|
Buchanan |
Tel: +44 (0) 20 7466 5000 |
|
Mark Court / Sophie Cowles / Stephanie Watson |
|
Notes for editors:
About Nanoco Group plc
Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nano-materials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, it has an exclusive manufacturing and marketing licensing agreement with The Dow Chemical Company.
Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate.
Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.
1 Year Evolutec Chart |
1 Month Evolutec Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
